![Dong-Young Son](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dong-Young Son
Corporate Officer/Principal bij Pai Chai University
Profiel
Dong-Young Son is a Professor at Pai Chai University since 2013.
He previously worked as an Independent Director at KB No.
3 Special Purpose Acquisition Co. and Sphere Power, Inc. Mr. Son completed his undergraduate degree at Seoul National University and his graduate degree at Konkuk University.
Actieve functies van Dong-Young Son
Bedrijven | Functie | Begin |
---|---|---|
Pai Chai University | Corporate Officer/Principal | 01-03-2013 |
Eerdere bekende functies van Dong-Young Son
Bedrijven | Functie | Einde |
---|---|---|
SPHERE POWER INC. | Directeur/Bestuurslid | - |
KB No. 3 Special Purpose Acquistion Co.
![]() KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Directeur/Bestuurslid | - |
Opleiding van Dong-Young Son
Seoul National University | Undergraduate Degree |
Konkuk University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SPHERE POWER INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
KB No. 3 Special Purpose Acquistion Co.
![]() KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Finance |